Blockchain intelligence firm Elliptic raises $5 million Series A

Blockchain intelligence firm Elliptic today announced a $5 million Series A funding round led by Paladin Capital Group, with participation from Santander InnoVentures, KRW Schindler, Digital Currency Group, and existing investor, Octopus Ventures. Christopher Steed, Managing Director of Paladin Capital Group, will join Elliptic’s board of directors alongside Octopus Ventures, and Santander InnoVentures will join as a board observer.

10x Genomics Completes $55 Million Series C Financing

10x Genomics, a company focused on improving and broadening the application of genomic information today announced the close of a $55 million Series C financing. The financing round was led by Fidelity Management & Research Company and included additional new investors Softbank and JS Capital Management LLC, alongside founding investors Venrock, Foresite Capital, and Paladin Capital.

Accenture and Endgame Form Alliance to Help Organizations Hunt, Block and Remove Cyber Adversaries

Accenture (NYSE: ACN) formed a new alliance relationship with Endgame Inc. – a provider of cybersecurity software solutions to actively hunt adversaries – to integrate the company’s sophisticated capabilities with Accenture’s cyber defense services. As part of the relationship, Accenture has also taken an equity position in Endgame. Terms of the investment were not disclosed.

The Dark Net: Policing the Internet’s Underworld

By Sir David Omand First published in the World Policy Journal Winter 2015/2016 LONDON—In 1910, one of the last remaining bands of outlaws of America’s Wild West emerged from their hideout in the Sierra Ladrones Mountains in New Mexico and …

Digital Shadows Announces $14 Million Series B Funding Raise

Digital Shadows, the only company to offer organizations cyber situational awareness, today announced that it has closed its Series B funding at $14 million, led by Trinity Ventures, with general partner Fred Wang joining the company’s Board of Directors. Existing investors Storm Ventures, TenEleven Ventures and Passion Capital also participated, and the company also welcomed new investor Paladin Capital Group.

Twist Bioscience Completes $61 Million Series D Financing and $20 Million Debt Facility

Twist Bioscience, a company accelerating science and innovation through rapid, high-quality DNA synthesis, today announced the completion of a $61 million Series D private financing. Crossover participants in the round include ARCH Overage Fund, Merieux Developpement, Cormorant Asset Management LLC, Fidelity Management and Research Company and Foresite Capital Management LLC. Additional investors include ARCH Venture Partners, WuXi Healthcare Ventures, Illumina, Inc., Nick and Joby Pritzker (through their family’s firm Tao Invest), Paladin Capital Group, Yuri Milner, Boris Nikolic and additional strategic corporate and venture investors.

Page 7 of 14« First...56789...Last »